Astellas Pharma Inc. (4503.T) is in Healthcare, Drug Manufacturers - General, based in Japan, listed on Tokyo. Market cap 4.03T JPY. 52-week range 1,557.50 to 2,717.00 JPY. Trailing P/E 11.1. Data as of 2026-10-09.
Astellas Pharma Inc. engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally. The company offers XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for acute myeloid leukemia; VYLOY, a treatment for gastric adenocarcinoma and esophagogastric junction adenocarcinoma; and PADCEV, a treatment for patients with metastatic urothelial carcinoma. It also provides VEOZAH, a treatment for vasomotor symptoms associated with menopause; ...